Next Article in Journal
Spirowallichiione: A Rearranged Multiflorane from Euphorbia wallichii Hook F. (Euphorbiaceae)
Next Article in Special Issue
Structure and Catalytic Properties of Carboxylesterase Isozymes Involved in Metabolic Activation of Prodrugs
Previous Article in Journal
Synthesis, Molecular Structure and Spectral Properties of Quaternary Ammonium Derivatives of 1,1-Dimethyl-1,3-propylenediamine
Previous Article in Special Issue
Design, Synthesis and Applications of Hyaluronic Acid-Paclitaxel Bioconjugates†
Article Menu

Export Article

Open AccessReview
Molecules 2008, 13(2), 391-404; doi:10.3390/molecules13020391

Novel Prodrugs for Targeting Diagnostic and Therapeutic Radionuclides to Solid Tumors

Department of Radiology, Harvard Medical School, Armenise Building, Room D2-137, 200 Longwood Avenue, Boston, Massachusetts 02115, USA
*
Author to whom correspondence should be addressed.
Received: 6 February 2008 / Revised: 15 February 2008 / Accepted: 15 February 2008 / Published: 18 February 2008
(This article belongs to the Special Issue Prodrugs)
View Full-Text   |   Download PDF [640 KB, uploaded 18 June 2014]   |  

Abstract

Most cancer therapeutics (chemo, radiation, antibody-based, anti-angiogenic)are at best partially and/or temporarily effective. In general, the causes for failure can besummarized as: (i) poor diffusion and/or nonuniform distribution of drug/prodrugmolecules in solid tumors; (ii) high drug concentration and retention in normal tissues(leading to side effects); (iii) requirement for plasma-membrane permeability and/orinternalization of drug/prodrug molecules; (iv) low uptake of drug by tumor; (v) lack ofretention of drug within tumor (most have gradient-driven reversible binding); and (vi)multidrug resistance. We are developing an innovative technology that aims to surmountthese problems by actively concentrating and permanently entrapping radioimaging andradiotherapeutic prodrugs specifically within solid tumors. The approach will enablenoninvasive sensing (imaging) and effective therapy of solid tumors, allowing tumordetection, diagnosis, and treatment to be closely coupled (personalized medicine). View Full-Text
Keywords: Prodrug; solid tumors; radioiodine; radioimaging; radiotherapy Prodrug; solid tumors; radioiodine; radioimaging; radiotherapy
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Kassis, A.I.; Korideck, H.; Wang, K.; Pospisil, P.; Adelstein, S.J. Novel Prodrugs for Targeting Diagnostic and Therapeutic Radionuclides to Solid Tumors. Molecules 2008, 13, 391-404.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top